Novel DPP-4 inhibitors against diabetes.

about

Response: economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patients (diabetes metab j 2015;39:74-81).Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone Disease.

P2860

Q35544036-FA5CEFB0-504C-452C-B97B-6749690EBD10 Q48371418-FDE02A7F-3CE3-4457-BA1B-6FBDCFE5A147

P2860

Novel DPP-4 inhibitors against diabetes.

Item

http://www.wikidata.org/entity/Q38221278

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Novel DPP-4 inhibitors against diabetes.

@en

type

Item

label

Novel DPP-4 inhibitors against diabetes.

@en

prefLabel

Novel DPP-4 inhibitors against diabetes.

@en

P1476

Novel DPP-4 inhibitors against diabetes.

@en

P2093

Yang Liu

http://www.w3.org/2001/XMLSchema#string

Yongzhou Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog

Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors

Rational design of a novel, potent, and orally bioavailable cyclohexylamine DPP-4 inhibitor by application of molecular modeling and X-ray crystallography of sitagliptin

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes

Synthesis and biological evaluation of homopiperazine derivatives with beta-aminoacyl group as dipeptidyl peptidase IV inhibitors

(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone: a potent, selective, orally active dipeptidyl peptidase IV inhibitor

Aminopiperidine-fused imidazoles as dipeptidyl peptidase-IV inhibitors

Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors

Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV

P304

793-808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4155/FMC.14.39

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24941873

http://www.w3.org/2001/XMLSchema#string

Novel DPP-4 inhibitors against diabetes.

about

P2860

P2860

Novel DPP-4 inhibitors against diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698